Blue Jet Healthcare Limited (BOM:544009)

Market Cap	80.69B -43.5%
Revenue (ttm)	9.47B -8.0%
Net Income	2.48B -18.8%
EPS	14.29 -18.8%
Shares Out	n/a
PE Ratio	32.56
Forward PE	26.98
Dividend	1.20 (0.25%)
Ex-Dividend Date	Sep 19, 2025

Volume	12,227
Open	481.25
Previous Close	475.80
Day's Range	461.70 - 481.25
52-Week Range	325.20 - 1,028.20
Beta	n/a
Analysts	Buy
Price Target	501.00 (+7.73%)
Earnings Date	May 25, 2026

About Blue Jet Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norw...

• Industry: Pharmaceutical Preparations
• Founded: 1968
• Employees: 196
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544009

Financial Performance

In fiscal year 2026, Blue Jet Healthcare's revenue was 9.47 billion, a decrease of -8.03% compared to the previous year's 10.30 billion. Earnings were 2.48 billion, a decrease of -18.80%.

Analyst Summary

According to 5 analysts, the average rating for 544009 stock is "Buy." The 12-month stock price target is ₹501.00, which is an increase of 7.73% from the latest price.

Price Target

₹501.00

(7.73% upside)

Analyst Consensus: Buy